Open AccessRetraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity
Publication year - 2022
Publication title -
clinical and translational immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.321
H-Index - 34
ISSN - 2050-0068
DOI - 10.1002/cti2.1378
Subject(s) - bispecific antibody , statement (logic) , immunity , dual (grammatical number) , antibody , medicine , cancer research , immunology , immune system , political science , philosophy , monoclonal antibody , linguistics , law